LG CNS (064400)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 72,800.00 |
|---|---|
| 52-week range | 54,100.00 – 153,300.00 |
| Return, 1 month / 3 months | +4.9% / +5.2% |
| Return, 1 year / 3 years | +22.4% / – |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 73.8% |
| Worst drawdown (1 year) | -59.5% |
| Average daily value traded | 51,201.49M KRW |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
LG CNS is a South Korean information technology services company based in Seoul. It provides systems integration, cloud computing, artificial intelligence and smart factory solutions, along with digital transformation consulting, to corporate and public sector clients. The company builds and operates the technology systems that other organisations rely on for their daily operations, and it works across industries such as manufacturing, finance and the public sector. It is part of the wider LG group of companies.
The shares are listed on the Korea Stock Exchange in Korea under the code 064400, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
LG CNS (064400) trades on the Korea Stock Exchange in Korea. It last closed at KRW 72,800.00 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 337 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.4% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -49.3% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | 8.5% | ||
| 12-month return, skipping the last month | 16.7% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -59.5% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 51,201.49M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 20 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 2 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +11.7% |
|---|---|
| 1 month | +4.9% |
| 3 months | +5.2% |
| 6 months | +8.5% |
| 1 year | +22.4% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 71,670.89 / 71,108.68 |
|---|---|
| Golden / death cross (60 days) | Golden, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3,402.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | KRW 750.0000 |
| 30 Mar 2026 | KRW 1,100.0000 |
| 20 Aug 2025 | KRW 750.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.